Tagged: "Xtandi"

XTANDI contains the active ingredient Enzalutamide. It is used in the treatment of advanced prostate cancer in patients who no longer responds to a hormone therapy or surgery to reduce testosterone and who is at high risk of cancer spreading to other parts of the body.

Showing the single result